DS-TB
Showing 1 - 25 of 1,832
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and
Not yet recruiting
- Pulmonary Tuberculosis
- Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
- +3 more
- (no location specified)
Jul 25, 2023
Tuberculosis, Pulmonary Trial in New Delhi, Tripura (RUTI®, Placebo)
Recruiting
- Tuberculosis, Pulmonary
- RUTI®
- Placebo
-
New Delhi, India
- +1 more
Mar 24, 2022
HIV-associated Tuberculosis Trial in South Africa, Thailand (Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC,
Not yet recruiting
- HIV-associated Tuberculosis
- Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC
- +3 more
-
Mowbray, Cape Town, Western Cape, South Africa
- +3 more
Nov 18, 2022
Tuberculosis, Pediatric Trial in Worldwide (Innovative approached to pediatric TB care)
Completed
- Tuberculosis
- Pediatric
- Innovative approached to pediatric TB care
-
Djoungolo, Cameroon
- +9 more
Jul 21, 2022
Start Taking Action For TB Diagnosis
Not yet recruiting
- Diagnosis
- Tuberculosis
- Molecular Diagnostics
- +4 more
- (no location specified)
Apr 25, 2023
Pulmonary TB Trial in South Africa (Delamanid + Bedaquiline + OPC-167832 10 mg, Delamanid + Bedaquiline + OPC-167832 30 mg,
Recruiting
- Pulmonary TB
- Delamanid + Bedaquiline + OPC-167832 10 mg
- +3 more
-
Tembisa, Gauteng, South Africa
- +7 more
Jun 30, 2022
Tuberculosis Infection, Tuberculosis Trial (BCG vaccine, Oral Chemoprophylaxis)
Not yet recruiting
- Tuberculosis Infection
- Tuberculosis
- BCG vaccine
- Oral Chemoprophylaxis
- (no location specified)
Jul 4, 2022
Atopic Dermatitis Trial in Worldwide (Crisaborole ointment, 2%, Hydrocortisone butyrate cream, 0.1%, Pimecrolimus cream, 1%)
Terminated
- Atopic Dermatitis
- Crisaborole ointment, 2%
- +3 more
-
Bryant, Arkansas
- +31 more
Dec 8, 2021
Tuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary Trial in Tbilisi (therapeutical surgery for TB)
Active, not recruiting
- Tuberculosis
- +3 more
- therapeutical surgery for TB
-
Tbilisi, GeorgiaNational Center for Tuberculosis and Lung Diseases
Sep 9, 2022
Tuberculosis, Pulmonary Trial in Godoy Cruz (RUTI® Vaccine, Placebo)
Not yet recruiting
- Tuberculosis, Pulmonary
- RUTI® Vaccine
- Placebo
-
Godoy Cruz, Mendoza, ArgentinaHospital José Nestor Lencinas
Jul 26, 2022
Tuberculosis, Pulmonary, Tuberculosis, MDR, Tuberculosis Infection Trial in Tbilisi, Soweto, Klerksdorp (Control group, ASA
Recruiting
- Tuberculosis, Pulmonary
- +2 more
- Control group
- +3 more
-
Tbilisi, Georgia
- +2 more
Apr 6, 2021
Tuberculosis Research of INA-RESPOND On Drug Resistance
Completed
- Lung Tuberculosis
- MDR TB
- No Intervention
-
Denpasar, Bali, Indonesia
- +6 more
Nov 17, 2021
Tuberculosis, Latent Tuberculosis, HIV/AIDS Trial in Kampala (Streamlined weekly DOT visits, Weekly DOT visit reminders, Cost
Active, not recruiting
- Tuberculosis
- +2 more
- Streamlined weekly DOT visits
- +5 more
-
Kampala, UgandaMulago Immune Suppression Syndrome (ISS) Clinic
Nov 28, 2022
Tuberculosis, Treatment Adherence Trial in Buenos Aires (TB treatment assistant)
Recruiting
- Tuberculosis
- Treatment Adherence
- TB treatment assistant
-
Buenos Aires, ArgentinaIECS
Mar 10, 2022
Severe Obesity Trial in Lille (sleeve gastrectomy with transit bipartition (SG +TB), Roux-en-Y gastric bypass (RYGB))
Recruiting
- Severe Obesity
- sleeve gastrectomy with transit bipartition (SG +TB)
- Roux-en-Y gastric bypass (RYGB)
-
Lille, FranceHop Claude Huriez Chu Lille
Mar 14, 2022
MDR-TB, HIV Trial in South Africa (NCM-Plus)
Active, not recruiting
- MDR-TB
- HIV
- NCM-Plus
-
Westville, Durban, South Africa
- +14 more
Nov 16, 2021
Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)
Not yet recruiting
- Tuberculosis
- Human Immunodeficiency Virus
- Optimised rifamycin
- (no location specified)
Oct 8, 2022
Tuberculosis, Adherence, Patient, Adherence, Medication Trial in Nairobi (Keheala Mobile Health Platform and Behavioral
Completed
- Tuberculosis
- +3 more
- Keheala Mobile Health Platform and Behavioral Interventions
- +3 more
-
Nairobi, KenyaKenya National TB Program
Jan 6, 2022
Tuberculosis Trial in Kampala (DOT Selfie Intervention, In-person DOT)
Recruiting
- Tuberculosis
- DOT Selfie Intervention
- In-person DOT
-
Kampala, UgandaUniversity of Makerere School of Public Health
Nov 4, 2021
Periodontitis, Trisomy 21 Trial in Ivry-sur-Seine (Screening visit (J-21), Inclusion visit (J0))
Not yet recruiting
- Periodontitis
- Trisomy 21
- Screening visit (J-21)
- Inclusion visit (J0)
-
Ivry-sur-Seine, FranceCarles-Foix Hospital
Jul 24, 2023
Down Syndrome Trial (cognitive motor dual task exercises, exergaming)
Not yet recruiting
- Down Syndrome
- cognitive motor dual task exercises
- exergaming
- (no location specified)
Nov 24, 2023
Tuberculosis, Extrapulmonary Trial in South Africa, Zambia, Zimbabwe (IRISA-TB)
Recruiting
- Tuberculosis, Extrapulmonary
- IRISA-TB
-
Durban, KwaZulu-Natal, South Africa
- +3 more
Nov 13, 2023